Daiichi Sankyo, AstraZeneca, Summit Therapeutics Launch Clinical Trial Collaboration

Daiichi Sankyo and AstraZeneca will collaborate with Summit Therapeutics to evaluate datopotamab deruxtecan in combination with ivonescimab across multiple tumor types, including lung and breast cancer.